Yuri Zarate
Concepts (408)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Matrix Attachment Region Binding Proteins | 14 | 2023 | 31 | 8.260 |
Why?
| Transcription Factors | 15 | 2023 | 622 | 5.500 |
Why?
| Phenotype | 24 | 2023 | 819 | 4.630 |
Why?
| Intellectual Disability | 18 | 2023 | 150 | 4.230 |
Why?
| Genetic Association Studies | 11 | 2021 | 136 | 3.680 |
Why?
| Mutation | 23 | 2023 | 1504 | 3.470 |
Why?
| Abnormalities, Multiple | 11 | 2021 | 162 | 3.300 |
Why?
| Syndrome | 18 | 2023 | 253 | 2.200 |
Why?
| Developmental Disabilities | 6 | 2021 | 127 | 2.040 |
Why?
| Genetic Diseases, Inborn | 3 | 2021 | 26 | 2.030 |
Why?
| Child, Preschool | 34 | 2022 | 4158 | 2.000 |
Why?
| Infant | 32 | 2021 | 3829 | 1.720 |
Why?
| Urogenital Abnormalities | 3 | 2019 | 19 | 1.720 |
Why?
| Male | 57 | 2023 | 27347 | 1.430 |
Why?
| Humans | 82 | 2023 | 54391 | 1.370 |
Why?
| Child | 32 | 2021 | 7368 | 1.370 |
Why?
| Beckwith-Wiedemann Syndrome | 4 | 2014 | 7 | 1.320 |
Why?
| Cardiovascular Abnormalities | 3 | 2019 | 26 | 1.310 |
Why?
| Marfan Syndrome | 4 | 2022 | 23 | 1.260 |
Why?
| Genetic Predisposition to Disease | 3 | 2021 | 570 | 1.240 |
Why?
| Female | 51 | 2023 | 28471 | 1.230 |
Why?
| Craniofacial Abnormalities | 3 | 2020 | 27 | 1.200 |
Why?
| Microcephaly | 3 | 2021 | 44 | 1.200 |
Why?
| Adolescent | 26 | 2021 | 6900 | 1.110 |
Why?
| Genotype | 5 | 2021 | 600 | 1.100 |
Why?
| Epilepsy | 4 | 2021 | 191 | 1.080 |
Why?
| Sequence Deletion | 3 | 2014 | 99 | 1.080 |
Why?
| Chromosomes, Human, Pair 2 | 3 | 2021 | 29 | 1.060 |
Why?
| Aortic Diseases | 2 | 2015 | 55 | 1.010 |
Why?
| Chromosome Deletion | 3 | 2021 | 150 | 0.980 |
Why?
| Young Adult | 17 | 2021 | 4318 | 0.980 |
Why?
| Infant, Newborn | 18 | 2022 | 2923 | 0.930 |
Why?
| Osteochondrodysplasias | 2 | 2021 | 14 | 0.910 |
Why?
| Nervous System Malformations | 2 | 2020 | 18 | 0.910 |
Why?
| Face | 3 | 2021 | 66 | 0.900 |
Why?
| Bone Diseases, Metabolic | 1 | 2023 | 84 | 0.880 |
Why?
| Growth Charts | 1 | 2022 | 7 | 0.870 |
Why?
| Facies | 6 | 2021 | 35 | 0.830 |
Why?
| Williams Syndrome | 3 | 2020 | 29 | 0.820 |
Why?
| Failure to Thrive | 2 | 2021 | 21 | 0.810 |
Why?
| Energy Metabolism | 2 | 2021 | 311 | 0.810 |
Why?
| Craniosynostoses | 2 | 2021 | 29 | 0.810 |
Why?
| Mutation, Missense | 6 | 2021 | 117 | 0.800 |
Why?
| Infant, Newborn, Diseases | 1 | 2022 | 65 | 0.800 |
Why?
| Growth Disorders | 2 | 2019 | 63 | 0.790 |
Why?
| Genomics | 2 | 2021 | 313 | 0.790 |
Why?
| Genetics, Medical | 1 | 2020 | 6 | 0.790 |
Why?
| Noonan Syndrome | 3 | 2021 | 12 | 0.770 |
Why?
| Leukoencephalopathies | 2 | 2020 | 17 | 0.770 |
Why?
| Sulfatases | 1 | 2020 | 7 | 0.760 |
Why?
| Genetic Variation | 1 | 2021 | 253 | 0.710 |
Why?
| Language Development Disorders | 2 | 2020 | 18 | 0.710 |
Why?
| alpha-Galactosidase | 2 | 2009 | 9 | 0.700 |
Why?
| Fabry Disease | 2 | 2009 | 9 | 0.700 |
Why?
| Aorta | 3 | 2020 | 177 | 0.690 |
Why?
| Mouth Diseases | 1 | 2019 | 6 | 0.690 |
Why?
| Receptors, GABA-B | 1 | 2019 | 12 | 0.690 |
Why?
| Speech | 1 | 2019 | 55 | 0.680 |
Why?
| Epilepsy, Absence | 1 | 2019 | 11 | 0.680 |
Why?
| Dental Pulp Cavity | 1 | 2018 | 5 | 0.680 |
Why?
| Tooth Abnormalities | 1 | 2018 | 10 | 0.670 |
Why?
| Adult | 22 | 2023 | 14207 | 0.660 |
Why?
| Congenital Abnormalities | 2 | 2019 | 112 | 0.650 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 176 | 0.650 |
Why?
| Language | 1 | 2019 | 137 | 0.640 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2019 | 153 | 0.640 |
Why?
| Mosaicism | 2 | 2015 | 18 | 0.640 |
Why?
| Brain | 3 | 2016 | 1392 | 0.630 |
Why?
| Craniotomy | 1 | 2017 | 25 | 0.620 |
Why?
| Feeding Behavior | 1 | 2019 | 200 | 0.610 |
Why?
| Genetic Testing | 4 | 2016 | 135 | 0.610 |
Why?
| Microtubule-Associated Proteins | 2 | 2021 | 78 | 0.600 |
Why?
| Thalamus | 1 | 2016 | 33 | 0.580 |
Why?
| Chromosomes, Human, X | 2 | 2015 | 21 | 0.580 |
Why?
| Acidosis | 1 | 2016 | 38 | 0.580 |
Why?
| Hand Deformities, Congenital | 1 | 2016 | 5 | 0.580 |
Why?
| Child Development | 2 | 2010 | 204 | 0.580 |
Why?
| Micrognathism | 1 | 2016 | 3 | 0.570 |
Why?
| Brain Stem | 1 | 2016 | 46 | 0.570 |
Why?
| Cafe-au-Lait Spots | 1 | 2016 | 2 | 0.570 |
Why?
| Neurocutaneous Syndromes | 1 | 2016 | 6 | 0.560 |
Why?
| Lactic Acid | 1 | 2016 | 90 | 0.560 |
Why?
| Fractures, Bone | 2 | 2019 | 118 | 0.560 |
Why?
| Chromosomal Proteins, Non-Histone | 1 | 2016 | 44 | 0.560 |
Why?
| Hemizygote | 1 | 2015 | 6 | 0.550 |
Why?
| Brain Diseases | 3 | 2021 | 88 | 0.550 |
Why?
| Osteogenesis Imperfecta | 1 | 2016 | 38 | 0.550 |
Why?
| Iron Metabolism Disorders | 1 | 2015 | 8 | 0.550 |
Why?
| Genetic Diseases, X-Linked | 1 | 2015 | 10 | 0.550 |
Why?
| Neuroaxonal Dystrophies | 1 | 2015 | 9 | 0.540 |
Why?
| Collagen Type I | 1 | 2016 | 97 | 0.530 |
Why?
| Neck | 1 | 2016 | 116 | 0.530 |
Why?
| Hypertelorism | 1 | 2015 | 4 | 0.530 |
Why?
| Syndactyly | 1 | 2015 | 4 | 0.530 |
Why?
| Toes | 1 | 2015 | 19 | 0.520 |
Why?
| Anal Canal | 1 | 2015 | 23 | 0.520 |
Why?
| Mitochondrial Diseases | 1 | 2016 | 109 | 0.520 |
Why?
| Receptor, Notch1 | 1 | 2014 | 4 | 0.520 |
Why?
| Cleft Lip | 2 | 2018 | 37 | 0.510 |
Why?
| Muscle Hypotonia | 2 | 2017 | 24 | 0.510 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2014 | 20 | 0.510 |
Why?
| Congenital Hyperinsulinism | 1 | 2014 | 2 | 0.510 |
Why?
| Chromosome Disorders | 1 | 2015 | 39 | 0.510 |
Why?
| Uniparental Disomy | 1 | 2014 | 12 | 0.510 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 474 | 0.500 |
Why?
| Ribonucleoprotein, U5 Small Nuclear | 1 | 2014 | 2 | 0.500 |
Why?
| Peptide Elongation Factors | 1 | 2014 | 4 | 0.500 |
Why?
| Histone-Lysine N-Methyltransferase | 1 | 2014 | 58 | 0.500 |
Why?
| Chromosome Duplication | 1 | 2014 | 7 | 0.500 |
Why?
| Mandibulofacial Dysostosis | 1 | 2014 | 4 | 0.500 |
Why?
| Chromosomes, Human, Pair 7 | 1 | 2014 | 30 | 0.490 |
Why?
| Chromosomes, Human, Pair 17 | 1 | 2014 | 43 | 0.480 |
Why?
| Dentofacial Deformities | 1 | 2013 | 1 | 0.480 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2013 | 20 | 0.470 |
Why?
| raf Kinases | 1 | 2013 | 5 | 0.470 |
Why?
| Carrier Proteins | 1 | 2015 | 360 | 0.470 |
Why?
| Child Abuse | 1 | 2016 | 170 | 0.460 |
Why?
| Nuclear Proteins | 3 | 2021 | 253 | 0.460 |
Why?
| Hypoplastic Left Heart Syndrome | 1 | 2014 | 97 | 0.460 |
Why?
| Cerebrovascular Disorders | 1 | 2013 | 53 | 0.460 |
Why?
| DNA-Binding Proteins | 1 | 2016 | 462 | 0.450 |
Why?
| Exome | 4 | 2017 | 51 | 0.450 |
Why?
| Signal Transduction | 2 | 2023 | 1752 | 0.440 |
Why?
| Heterozygote | 5 | 2021 | 96 | 0.430 |
Why?
| Trisomy | 2 | 2014 | 34 | 0.420 |
Why?
| Kidney | 2 | 2015 | 822 | 0.420 |
Why?
| Heart Defects, Congenital | 2 | 2015 | 608 | 0.410 |
Why?
| Retrospective Studies | 10 | 2022 | 6459 | 0.400 |
Why?
| Sex Chromosome Disorders of Sex Development | 1 | 2010 | 3 | 0.390 |
Why?
| Sex Chromosome Aberrations | 1 | 2010 | 8 | 0.390 |
Why?
| Acrocephalosyndactylia | 1 | 2010 | 2 | 0.370 |
Why?
| Digestive System Abnormalities | 1 | 2010 | 6 | 0.370 |
Why?
| Intestinal Volvulus | 1 | 2010 | 7 | 0.370 |
Why?
| Growth | 1 | 2010 | 43 | 0.360 |
Why?
| Nephrosis, Lipoid | 1 | 2009 | 7 | 0.360 |
Why?
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2020 | 21 | 0.360 |
Why?
| Jejunum | 1 | 2010 | 56 | 0.360 |
Why?
| Fetofetal Transfusion | 1 | 2009 | 6 | 0.360 |
Why?
| Melanosomes | 1 | 2009 | 1 | 0.350 |
Why?
| Skin Pigmentation | 1 | 2009 | 4 | 0.350 |
Why?
| Vomiting | 1 | 2010 | 73 | 0.350 |
Why?
| Pigmentation Disorders | 1 | 2009 | 8 | 0.350 |
Why?
| Hyperplasia | 1 | 2009 | 107 | 0.350 |
Why?
| Melanocytes | 1 | 2009 | 39 | 0.340 |
Why?
| Radiography, Panoramic | 2 | 2019 | 10 | 0.340 |
Why?
| Translocation, Genetic | 1 | 2010 | 287 | 0.340 |
Why?
| Diagnosis, Differential | 4 | 2016 | 1141 | 0.330 |
Why?
| In Situ Hybridization, Fluorescence | 3 | 2014 | 278 | 0.320 |
Why?
| Hearing Loss, Sensorineural | 1 | 2009 | 83 | 0.320 |
Why?
| Glucose Transport Proteins, Facilitative | 2 | 2018 | 10 | 0.320 |
Why?
| Fetus | 1 | 2009 | 228 | 0.310 |
Why?
| Skin Diseases, Genetic | 2 | 2018 | 11 | 0.310 |
Why?
| Tumor Suppressor Proteins | 2 | 2020 | 141 | 0.300 |
Why?
| Arteries | 2 | 2018 | 101 | 0.300 |
Why?
| Joint Instability | 2 | 2018 | 59 | 0.300 |
Why?
| Chromosomes, Human, Pair 11 | 1 | 2007 | 54 | 0.300 |
Why?
| Comparative Genomic Hybridization | 3 | 2020 | 50 | 0.300 |
Why?
| Intelligence | 1 | 2007 | 63 | 0.290 |
Why?
| Autistic Disorder | 3 | 2019 | 135 | 0.280 |
Why?
| Magnetic Resonance Angiography | 2 | 2017 | 80 | 0.280 |
Why?
| Echocardiography | 4 | 2020 | 392 | 0.280 |
Why?
| Magnetic Resonance Imaging | 4 | 2020 | 1616 | 0.280 |
Why?
| Cleft Palate | 2 | 2018 | 72 | 0.270 |
Why?
| Alkaline Phosphatase | 2 | 2023 | 99 | 0.270 |
Why?
| Vascular Malformations | 2 | 2018 | 101 | 0.270 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2019 | 552 | 0.270 |
Why?
| Alleles | 2 | 2016 | 277 | 0.260 |
Why?
| Body Weight | 2 | 2022 | 578 | 0.260 |
Why?
| Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2017 | 11 | 0.250 |
Why?
| Cerebellum | 3 | 2021 | 142 | 0.250 |
Why?
| Reproducibility of Results | 2 | 2022 | 1301 | 0.240 |
Why?
| High-Throughput Nucleotide Sequencing | 2 | 2016 | 206 | 0.240 |
Why?
| Zebrafish | 2 | 2021 | 58 | 0.240 |
Why?
| Animals | 7 | 2023 | 14409 | 0.240 |
Why?
| Drosophila Proteins | 1 | 2023 | 17 | 0.230 |
Why?
| Lymphopenia | 1 | 2023 | 21 | 0.220 |
Why?
| Absorptiometry, Photon | 1 | 2023 | 174 | 0.220 |
Why?
| Comorbidity | 2 | 2015 | 664 | 0.220 |
Why?
| Caenorhabditis elegans Proteins | 1 | 2023 | 60 | 0.220 |
Why?
| Color Vision Defects | 1 | 2022 | 1 | 0.220 |
Why?
| Rod Opsins | 1 | 2022 | 2 | 0.220 |
Why?
| Pedigree | 3 | 2020 | 146 | 0.220 |
Why?
| Microarray Analysis | 2 | 2014 | 85 | 0.220 |
Why?
| Guanine Nucleotide Exchange Factors | 2 | 2023 | 17 | 0.210 |
Why?
| Costello Syndrome | 1 | 2021 | 1 | 0.210 |
Why?
| Adaptor Proteins, Signal Transducing | 2 | 2023 | 208 | 0.210 |
Why?
| Argonaute Proteins | 1 | 2021 | 11 | 0.210 |
Why?
| Ectodermal Dysplasia | 1 | 2021 | 7 | 0.210 |
Why?
| Nervous System Diseases | 1 | 2023 | 97 | 0.210 |
Why?
| Kidney Diseases, Cystic | 1 | 2021 | 20 | 0.210 |
Why?
| Eye Abnormalities | 1 | 2021 | 22 | 0.200 |
Why?
| Exons | 3 | 2020 | 105 | 0.200 |
Why?
| Ventricular Dysfunction, Left | 1 | 2022 | 99 | 0.200 |
Why?
| Collagen Type V | 1 | 2021 | 4 | 0.200 |
Why?
| Dwarfism | 1 | 2021 | 4 | 0.200 |
Why?
| Collagen Type III | 1 | 2021 | 10 | 0.200 |
Why?
| Synaptosomal-Associated Protein 25 | 1 | 2020 | 3 | 0.200 |
Why?
| Latin America | 1 | 2020 | 10 | 0.200 |
Why?
| Bone Density | 1 | 2023 | 416 | 0.200 |
Why?
| Registries | 2 | 2021 | 553 | 0.200 |
Why?
| Cyclin-Dependent Kinases | 1 | 2021 | 35 | 0.190 |
Why?
| Thinness | 1 | 2021 | 57 | 0.190 |
Why?
| Cardiomyopathies | 1 | 2022 | 131 | 0.190 |
Why?
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2021 | 35 | 0.190 |
Why?
| Myofibromatosis | 1 | 2020 | 2 | 0.190 |
Why?
| Blepharophimosis | 1 | 2020 | 4 | 0.190 |
Why?
| Sulfotransferases | 1 | 2020 | 43 | 0.190 |
Why?
| Sleep Stages | 1 | 2020 | 46 | 0.190 |
Why?
| Diacylglycerol O-Acyltransferase | 1 | 2019 | 5 | 0.180 |
Why?
| Age of Onset | 1 | 2020 | 117 | 0.180 |
Why?
| Japan | 1 | 2019 | 26 | 0.180 |
Why?
| Prevalence | 3 | 2022 | 1025 | 0.180 |
Why?
| Social Behavior Disorders | 1 | 2019 | 7 | 0.180 |
Why?
| Apraxias | 1 | 2019 | 11 | 0.180 |
Why?
| Abnormalities, Radiation-Induced | 1 | 2019 | 7 | 0.180 |
Why?
| Codon, Terminator | 1 | 2019 | 8 | 0.180 |
Why?
| Bone and Bones | 1 | 2023 | 515 | 0.180 |
Why?
| Hypophosphatasia | 1 | 2019 | 8 | 0.170 |
Why?
| Diarrhea | 1 | 2019 | 90 | 0.170 |
Why?
| Dilatation, Pathologic | 2 | 2017 | 22 | 0.170 |
Why?
| Gene Deletion | 2 | 2022 | 293 | 0.170 |
Why?
| Gestational Age | 1 | 2021 | 435 | 0.170 |
Why?
| Hypertension, Pulmonary | 1 | 2021 | 126 | 0.170 |
Why?
| Body Mass Index | 1 | 2022 | 712 | 0.170 |
Why?
| Radiography, Dental | 1 | 2018 | 4 | 0.170 |
Why?
| Child Behavior Disorders | 1 | 2019 | 87 | 0.170 |
Why?
| Gene Rearrangement | 1 | 2019 | 76 | 0.170 |
Why?
| Trans-Activators | 1 | 2020 | 147 | 0.170 |
Why?
| Cell Nucleus | 1 | 2019 | 203 | 0.170 |
Why?
| Malnutrition | 1 | 2019 | 82 | 0.170 |
Why?
| Pierre Robin Syndrome | 1 | 2018 | 5 | 0.160 |
Why?
| Cystic Fibrosis | 1 | 2021 | 157 | 0.160 |
Why?
| Lip | 1 | 2018 | 11 | 0.160 |
Why?
| Genes, X-Linked | 2 | 2020 | 8 | 0.160 |
Why?
| Inheritance Patterns | 1 | 2018 | 27 | 0.160 |
Why?
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2017 | 8 | 0.160 |
Why?
| Hernia, Diaphragmatic | 1 | 2018 | 23 | 0.160 |
Why?
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2017 | 18 | 0.160 |
Why?
| Electroencephalography | 1 | 2020 | 357 | 0.160 |
Why?
| Motor Activity | 1 | 2019 | 249 | 0.160 |
Why?
| Cysts | 1 | 2018 | 50 | 0.160 |
Why?
| Keratoconus | 1 | 2017 | 4 | 0.150 |
Why?
| Myopia | 1 | 2017 | 8 | 0.150 |
Why?
| Respiratory Distress Syndrome, Newborn | 1 | 2018 | 53 | 0.150 |
Why?
| Communication | 1 | 2019 | 265 | 0.150 |
Why?
| Phosphorylation | 1 | 2019 | 613 | 0.150 |
Why?
| Glutamate-tRNA Ligase | 1 | 2016 | 4 | 0.150 |
Why?
| Cornea | 1 | 2017 | 62 | 0.150 |
Why?
| Prospective Studies | 1 | 2023 | 2606 | 0.150 |
Why?
| Histones | 1 | 2019 | 335 | 0.150 |
Why?
| Endoscopy | 1 | 2017 | 131 | 0.150 |
Why?
| Fibroblasts | 2 | 2020 | 386 | 0.140 |
Why?
| Pathology, Molecular | 1 | 2016 | 24 | 0.140 |
Why?
| Osteoblasts | 1 | 2019 | 514 | 0.140 |
Why?
| Liver Diseases | 1 | 2016 | 87 | 0.140 |
Why?
| Population Surveillance | 1 | 2016 | 183 | 0.130 |
Why?
| Germ-Line Mutation | 1 | 2015 | 68 | 0.130 |
Why?
| Frameshift Mutation | 1 | 2015 | 17 | 0.130 |
Why?
| Aneuploidy | 1 | 2015 | 23 | 0.130 |
Why?
| Codon, Nonsense | 1 | 2015 | 29 | 0.130 |
Why?
| Multicystic Dysplastic Kidney | 1 | 2014 | 2 | 0.130 |
Why?
| Ring Chromosomes | 1 | 2014 | 7 | 0.130 |
Why?
| Arkansas | 2 | 2019 | 2100 | 0.130 |
Why?
| Anus, Imperforate | 1 | 2014 | 8 | 0.130 |
Why?
| Disorders of Sex Development | 1 | 2014 | 7 | 0.130 |
Why?
| Heart Valve Diseases | 1 | 2015 | 42 | 0.130 |
Why?
| Chromosomes, Human, Pair 13 | 1 | 2014 | 41 | 0.130 |
Why?
| Skin | 2 | 2018 | 469 | 0.130 |
Why?
| Karyotyping | 1 | 2014 | 92 | 0.130 |
Why?
| Aortic Aneurysm | 1 | 2014 | 29 | 0.120 |
Why?
| Sequence Analysis, DNA | 1 | 2015 | 274 | 0.120 |
Why?
| Aortic Valve | 1 | 2015 | 116 | 0.120 |
Why?
| Chromosome Mapping | 1 | 2014 | 175 | 0.120 |
Why?
| Tomography Scanners, X-Ray Computed | 1 | 2013 | 14 | 0.120 |
Why?
| Pregnancy | 4 | 2019 | 2639 | 0.120 |
Why?
| Amino Acid Sequence | 3 | 2021 | 767 | 0.120 |
Why?
| Cohort Studies | 4 | 2020 | 1546 | 0.110 |
Why?
| Disease Models, Animal | 1 | 2019 | 1647 | 0.110 |
Why?
| Chromosome Aberrations | 1 | 2015 | 316 | 0.110 |
Why?
| DNA Copy Number Variations | 1 | 2012 | 114 | 0.110 |
Why?
| Macroglossia | 1 | 2012 | 1 | 0.110 |
Why?
| Time Factors | 1 | 2019 | 3210 | 0.110 |
Why?
| Genes, Neurofibromatosis 1 | 1 | 2011 | 3 | 0.100 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2011 | 6 | 0.100 |
Why?
| Severity of Illness Index | 1 | 2015 | 1082 | 0.100 |
Why?
| Neurofibromatoses | 1 | 2011 | 6 | 0.100 |
Why?
| Genitalia | 1 | 2010 | 15 | 0.100 |
Why?
| Duodenogastric Reflux | 1 | 2010 | 1 | 0.090 |
Why?
| Cephalometry | 1 | 2010 | 21 | 0.090 |
Why?
| Delayed Diagnosis | 1 | 2010 | 25 | 0.090 |
Why?
| Hospitalization | 1 | 2014 | 704 | 0.090 |
Why?
| Kidney Function Tests | 1 | 2009 | 59 | 0.090 |
Why?
| alpha-Fetoproteins | 1 | 2009 | 15 | 0.090 |
Why?
| Podocytes | 1 | 2009 | 25 | 0.090 |
Why?
| Intestinal Obstruction | 1 | 2010 | 37 | 0.090 |
Why?
| Hair Color | 1 | 2009 | 10 | 0.090 |
Why?
| Kidney Glomerulus | 1 | 2009 | 61 | 0.090 |
Why?
| Twins, Monozygotic | 1 | 2009 | 18 | 0.090 |
Why?
| Potassium Channels, Voltage-Gated | 1 | 2009 | 14 | 0.090 |
Why?
| Steroids | 1 | 2009 | 55 | 0.090 |
Why?
| Melanins | 1 | 2009 | 31 | 0.090 |
Why?
| Creatinine | 1 | 2009 | 169 | 0.090 |
Why?
| Confidence Intervals | 1 | 2009 | 166 | 0.090 |
Why?
| Age Distribution | 1 | 2009 | 199 | 0.090 |
Why?
| RNA, Messenger | 2 | 2023 | 1203 | 0.080 |
Why?
| Acute Disease | 1 | 2009 | 403 | 0.080 |
Why?
| Anti-Inflammatory Agents | 1 | 2009 | 175 | 0.080 |
Why?
| Radiography | 1 | 2009 | 526 | 0.080 |
Why?
| Patient Compliance | 1 | 2009 | 247 | 0.080 |
Why?
| Microfilament Proteins | 1 | 2007 | 47 | 0.080 |
Why?
| Immunotherapy | 1 | 2009 | 264 | 0.080 |
Why?
| Chromosome Banding | 1 | 2007 | 28 | 0.080 |
Why?
| Ultrasonography | 1 | 2009 | 486 | 0.070 |
Why?
| Risk Factors | 1 | 2015 | 3937 | 0.070 |
Why?
| Age Factors | 1 | 2010 | 1199 | 0.070 |
Why?
| Sex Factors | 1 | 2008 | 766 | 0.070 |
Why?
| Case-Control Studies | 1 | 2009 | 1229 | 0.070 |
Why?
| Ligases | 1 | 2023 | 11 | 0.060 |
Why?
| Agenesis of Corpus Callosum | 1 | 2023 | 9 | 0.060 |
Why?
| Drosophila | 1 | 2023 | 17 | 0.060 |
Why?
| Ubiquitins | 1 | 2023 | 40 | 0.060 |
Why?
| Corpus Callosum | 1 | 2023 | 28 | 0.060 |
Why?
| Liver | 1 | 2009 | 1226 | 0.060 |
Why?
| Retinal Cone Photoreceptor Cells | 1 | 2022 | 1 | 0.050 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2023 | 100 | 0.050 |
Why?
| Prognosis | 2 | 2019 | 2126 | 0.050 |
Why?
| Multigene Family | 1 | 2022 | 54 | 0.050 |
Why?
| Caenorhabditis elegans | 1 | 2023 | 147 | 0.050 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2023 | 131 | 0.050 |
Why?
| Cilia | 1 | 2021 | 9 | 0.050 |
Why?
| Hedgehog Proteins | 1 | 2021 | 33 | 0.050 |
Why?
| Stroke Volume | 1 | 2022 | 151 | 0.050 |
Why?
| Protein Stability | 1 | 2021 | 44 | 0.050 |
Why?
| Transcriptional Elongation Factors | 1 | 2021 | 28 | 0.050 |
Why?
| Gene Frequency | 1 | 2021 | 120 | 0.050 |
Why?
| Retina | 1 | 2021 | 65 | 0.050 |
Why?
| Haploinsufficiency | 1 | 2020 | 13 | 0.050 |
Why?
| NF-kappa B | 1 | 2023 | 336 | 0.050 |
Why?
| Ventricular Function, Left | 1 | 2022 | 182 | 0.050 |
Why?
| Evolution, Molecular | 1 | 2021 | 103 | 0.050 |
Why?
| Sinus of Valsalva | 1 | 2020 | 7 | 0.050 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2020 | 50 | 0.050 |
Why?
| Histone Acetyltransferases | 1 | 2020 | 22 | 0.050 |
Why?
| Basilar Artery | 1 | 2020 | 6 | 0.050 |
Why?
| Nonsense Mediated mRNA Decay | 1 | 2020 | 5 | 0.050 |
Why?
| Aneurysm | 1 | 2020 | 43 | 0.050 |
Why?
| Cell Nucleus Shape | 1 | 2019 | 1 | 0.040 |
Why?
| Growth and Development | 1 | 2019 | 16 | 0.040 |
Why?
| Carotid Arteries | 1 | 2020 | 82 | 0.040 |
Why?
| Truncus Arteriosus | 1 | 2019 | 8 | 0.040 |
Why?
| Models, Molecular | 1 | 2021 | 423 | 0.040 |
Why?
| Speech Disorders | 1 | 2019 | 18 | 0.040 |
Why?
| Live Birth | 1 | 2019 | 24 | 0.040 |
Why?
| Radioactive Hazard Release | 1 | 2019 | 15 | 0.040 |
Why?
| Pregnancy, Multiple | 1 | 2019 | 21 | 0.040 |
Why?
| Amino Acids | 1 | 2021 | 369 | 0.040 |
Why?
| Behavior | 1 | 2019 | 48 | 0.040 |
Why?
| Enzyme Replacement Therapy | 1 | 2019 | 19 | 0.040 |
Why?
| Sequence Homology | 1 | 2019 | 21 | 0.040 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 206 | 0.040 |
Why?
| Parturition | 1 | 2019 | 53 | 0.040 |
Why?
| Mice | 2 | 2021 | 6428 | 0.040 |
Why?
| Micronesia | 1 | 2019 | 118 | 0.040 |
Why?
| Nerve Tissue Proteins | 1 | 2020 | 200 | 0.040 |
Why?
| Fatal Outcome | 2 | 2011 | 225 | 0.040 |
Why?
| Imaging, Three-Dimensional | 1 | 2020 | 172 | 0.040 |
Why?
| Seizures | 1 | 2020 | 209 | 0.040 |
Why?
| Cataract | 1 | 2019 | 45 | 0.040 |
Why?
| Protein Kinase Inhibitors | 1 | 2020 | 216 | 0.040 |
Why?
| Interferon Regulatory Factors | 1 | 2018 | 18 | 0.040 |
Why?
| Smad2 Protein | 1 | 2018 | 4 | 0.040 |
Why?
| Connective Tissue Growth Factor | 1 | 2018 | 10 | 0.040 |
Why?
| Prader-Willi Syndrome | 1 | 2017 | 8 | 0.040 |
Why?
| Tongue | 1 | 2018 | 41 | 0.040 |
Why?
| Cell Cycle | 1 | 2019 | 275 | 0.040 |
Why?
| Ataxia | 1 | 2017 | 23 | 0.040 |
Why?
| Conserved Sequence | 1 | 2017 | 57 | 0.040 |
Why?
| Corneal Topography | 1 | 2017 | 6 | 0.040 |
Why?
| Corneal Pachymetry | 1 | 2017 | 7 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2020 | 922 | 0.040 |
Why?
| Learning | 1 | 2019 | 171 | 0.040 |
Why?
| Transforming Growth Factor beta | 1 | 2018 | 158 | 0.040 |
Why?
| Osteogenesis | 1 | 2019 | 377 | 0.040 |
Why?
| Cell Differentiation | 1 | 2019 | 720 | 0.040 |
Why?
| Cell Line | 1 | 2019 | 1152 | 0.030 |
Why?
| Tomography, Optical Coherence | 1 | 2017 | 148 | 0.030 |
Why?
| Pain | 1 | 2019 | 405 | 0.030 |
Why?
| Models, Biological | 1 | 2019 | 825 | 0.030 |
Why?
| Biopsy | 1 | 2018 | 692 | 0.030 |
Why?
| Cell Proliferation | 1 | 2019 | 1097 | 0.030 |
Why?
| Hospital Charges | 1 | 2014 | 50 | 0.030 |
Why?
| Gene Expression Regulation | 1 | 2019 | 1063 | 0.030 |
Why?
| Tomography, X-Ray Computed | 1 | 2020 | 1222 | 0.030 |
Why?
| Hospitals, Pediatric | 1 | 2014 | 270 | 0.030 |
Why?
| Pregnancy, Twin | 1 | 2012 | 7 | 0.030 |
Why?
| Diseases in Twins | 1 | 2012 | 16 | 0.030 |
Why?
| Hospital Mortality | 1 | 2014 | 466 | 0.030 |
Why?
| Diabetes, Gestational | 1 | 2012 | 54 | 0.020 |
Why?
| Length of Stay | 1 | 2014 | 683 | 0.020 |
Why?
| Cardiac Surgical Procedures | 1 | 2014 | 318 | 0.020 |
Why?
| Thymine | 1 | 2007 | 11 | 0.020 |
Why?
| Contracture | 1 | 2007 | 20 | 0.020 |
Why?
| Musculoskeletal Abnormalities | 1 | 2007 | 12 | 0.020 |
Why?
| Cytosine | 1 | 2007 | 29 | 0.020 |
Why?
| Early Diagnosis | 1 | 2007 | 96 | 0.020 |
Why?
| Prenatal Diagnosis | 1 | 2007 | 113 | 0.020 |
Why?
| Middle Aged | 1 | 2020 | 13082 | 0.020 |
Why?
| Cardiovascular Diseases | 1 | 2007 | 476 | 0.010 |
Why?
|
|
Zarate's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|